Unicycive Therapeutics, Inc. · NASDAQ:UNCY
Vivo Opportunity Fund Holdings, L.P. reported a 9.99% stake in Unicycive Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Vivo Opportunity Fund Holdings, L.P. reported a 9.99% stake in Unicycive Therapeutics, Inc., 4,856,259 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 4,856,259
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 9.99% | 4,856,259 |
| Vivo Opportunity, LLC | 9.99% | 4,856,259 |
Source
Related
- Unicycive Therapeutics, Inc.
- Vivo Opportunity, LLC
- Unicycive Therapeutics, Inc. shareholders
- Schedule 13G/A · Vivo Opportunity, LLC · Nov 14, 2025
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 8, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026